(Q36335090)

13 August 2017

1 reference

title

Thyrotropin receptor antibodies: advances and importance of detection techniques in thyroid diseases (English)

1 reference

13 August 2017

M. K. Gupta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1633635

18 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1633635

18 October 2022

publication date

1 June 1992

1 reference

full work available at URL

13 August 2017

https://api.elsevier.com/content/article/PII:0009912092903029?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

https://api.elsevier.com/content/article/PII:0009912092903029?httpAccept=text/plain

18 October 2022

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

18 October 2022

published in

Clinical Biochemistry

1 reference

13 August 2017

volume

25

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

193-199

1 reference

Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study

13 August 2017

cites work

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1210/JCEM-50-1-144

Multicomponent structure of the thyrotropin receptor: Relationship to Graves' disease

1

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Site-directed mutagenesis of the human thyrotropin receptor: role of asparagine-linked oligosaccharides in the expression of a functional receptor

18 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

An insertion in the human thyrotropin receptor critical for high affinity hormone binding

18 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies

18 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Immune mechanisms in Graves' disease

18 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

27 Measurement of thyrotropin receptor antibodies

18 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

A receptor assay for the measurement of TSH receptor antibodies in unextracted serum

18 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Delayed thyroid response to serum from thyrotoxic patients

18 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Studies on the thyroid activator of hyperthyroidism.

18 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Culture of hormone-dependent functional epithelial cells from rat thyroids

18 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Characterization of the Optimal Stimulatory Effects of Graves’ Monoclonal and Serum Immunoglobulin G on Adenosine 3′,5′-Monophosphate Production in FRTL-5 Thyroid Cells: A Potential Clinical Assay

18 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Graves’ IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay

18 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Characterization of thyroid-stimulating immunoglobulin-induced cyclic AMP accumulation in the rat thyroid cell strain FRTL-5: potentiation by forskolin and calibration against reference preparations of thyrotrophin

18 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol

18 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Pathophysiological role of thyroid blocking antibody in patients with primary hypothyroidism

18 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment

18 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Heterogeneity of the Graves' Immunoglobulins Directed toward the Thyrotropin Receptor-Adenylate Cyclase System*

18 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

The assay of Graves' immunoglobulins: a comparison of different methods

18 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Correlation between Thyroid Stimulators and 3,5,3′-Triiodothyronine Suppressibility in Patients during Treatment for Hyperthyroidism with Thionamide Drugs:Comparison of Assays by Thyroid-Stimulating and Thyrotropin-Displacing Activities*

18 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease

18 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Correlation between Thyrotropin-Displacing Activity and Human Thyroid-Stimulating Activity by Immunoglobulins from Patients with Graves' Disease and Other Thyroid Disorders*

18 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies

18 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies

18 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Characterization of monoclonal antibodies derived from lymphocytes from Graves' disease patients in a cytochemical bioassay for thyroid stimulators

18 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection

18 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Recombinant human thyrotropin (TSH) receptor in a radioreceptor assay for the measurement of TSH receptor autoantibodies

18 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease

18 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease

18 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Prognostic value of thyrotrophin binding inhibiting immunoglobulins (TBII) in longterm antithyroid treatment, 131I therapy given in combination with carbimazole and in euthyroid ophthalmopathy

18 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Thyroid stimulating antibodies (TSAb) in patients with Graves' disease undergoing antithyroid drug treatment: indicators of activity of disease

18 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Prediction of relapse in hyperthyroid Graves' disease

18 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Effects of radioiodine on thyrotrophin binding inhibiting immunoglobulins in Graves' disease

18 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

A Prospective Study of the Changes in Thyrotropin Binding Inhibitory Immunoglobulins in Graves' Disease Treated by Subtotal Thyroidectomy or Radioactive Iodine*

18 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy

18 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities.

18 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Clinical and laboratory findings in 15 patients

18 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action.

18 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Inhibition of thyrotropin-induced growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema

18 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Blocking activity to action of thyroid stimulating hormone in serum from patients with primary hypothyroidism

18 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins

18 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis

18 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Pathophysiological role of thyroid blocking antibody in patients with primary hypothyroidism

18 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Characterization of TSH antagonist activity in the serum of patients with thyroid disease

18 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

TSH receptor antibodies in autoimmune thyroiditis

18 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Familial Neonatal Transient Hypothyroidism Due to Maternal TSH-Binding Inhibitor Immunoglobulins

18 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis

18 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Detection and characterization of autoantibodies blocking the TSH-dependent cAMP production using FRTL-5 cells

18 October 2022

60

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.

18 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Maternal thyroid-blocking immunoglobulins in congenital hypothyroidism

18 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Maternal TSH-receptor antibodies and TSH antibodies in screening for congenital hypothyroidism

18 October 2022

63

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Further studies on thyroid growth-stimulating immunoglobulins in euthyroid nonendemic goiter

18 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies

18 October 2022

66

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Thyroid growth-stimulating immunoglobulins in goitrous disease: relationship to thyroid-stimulating immunoglobulins.

18 October 2022

67

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Assays for thyroid growth immunoglobulins and their clinical implications: methods, concepts, and misconceptions

18 October 2022

68

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Chromatographically purified immunoglobulin G of endemic and sporadic goiter patients stimulates FRTL5 cell growth in a mitotic arrest assay

18 October 2022

69

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Do thyroid growth-promoting immunoglobulins exist?

18 October 2022

70

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Thyroid carcinoma in Graves' disease

18 October 2022

71

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Thyroid carcinoma in thyrotoxic patients treated by surgery

18 October 2022

72

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Incidence of thyroid carcinoma in Graves' disease

18 October 2022

73

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Increased aggressiveness of thyroid cancer in patients with Graves' disease

18 October 2022

74

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma

18 October 2022

75

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer

18 October 2022

76

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90302-9

18 October 2022

Identifiers

1 reference

13 August 2017

1 reference